Canasa (mesalamine) NDC 58914-501

NDC codes

FDA NDC Directory

Product NDC (as listed)58914-501Labeler and product segments. Claims need a package NDC.

Product NDC at billing width58914-0501Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
58914-501-33	58914050133	3 SUPPOSITORY in 1 BOX (58914-501-33)Marketed from Jan 5, 2001 · Sample package
58914-501-42	58914050142	42 SUPPOSITORY in 1 BOX (58914-501-42)Marketed from Jan 5, 2001
58914-501-56	58914050156	30 SUPPOSITORY in 1 BOX (58914-501-56)Marketed from Jan 5, 2001

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Canasa
Generic name (nonproprietary): mesalamine
Active ingredients: Mesalamine — 1000 mg/1
Dosage form: Suppository
Route: Rectal
Labeler: Allergan, Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 021252
Marketing start: Jan 5, 2001
Listing expires: Dec 31, 2027
Other FDA classes: Aminosalicylic Acids (Chemical structure)
Identifiers: Product ID 58914-501_f6634219-3e94-4856-b896-67c3bd3b168dSPL ID f6634219-3e94-4856-b896-67c3bd3b168dSPL set ID 89d91601-152b-4398-bebe-af1c023e9935RxCUI 248420, 583257UNII 4Q81I59GXC
Pharmacologic class: Aminosalicylate

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N458914050133 followed by a unit qualifier and the quantity

Package 58914-0501-33. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 8, 2024.

Indications (excerpt from the label)

CANASA is indicated in adults for the treatment of mildly to moderately active ulcerative proctitis. CANASA is an aminosalicylate indicated in adults for the treatment of mildly to moderately active ulcerative proctitis. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)